232 related articles for article (PubMed ID: 32761725)
1. NIR-Absorbing Ru
Lifshits LM; Roque JA; Cole HD; Thummel RP; Cameron CG; McFarland SA
Chembiochem; 2020 Dec; 21(24):3594-3607. PubMed ID: 32761725
[TBL] [Abstract][Full Text] [Related]
2. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
3. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
[TBL] [Abstract][Full Text] [Related]
4. Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy.
Roque JA; Barrett PC; Cole HD; Lifshits LM; Bradner E; Shi G; von Dohlen D; Kim S; Russo N; Deep G; Cameron CG; Alberto ME; McFarland SA
Inorg Chem; 2020 Nov; 59(22):16341-16360. PubMed ID: 33126792
[TBL] [Abstract][Full Text] [Related]
5. Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents.
Cole HD; Vali A; Roque JA; Shi G; Kaur G; Hodges RO; Francés-Monerris A; Alberto ME; Cameron CG; McFarland SA
Inorg Chem; 2023 Dec; 62(51):21181-21200. PubMed ID: 38079387
[TBL] [Abstract][Full Text] [Related]
6. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (
Lifshits LM; Roque JA; Ramasamy E; Thummel RP; Cameron CG; McFarland SA
J Photochem Photobiol; 2021 Dec; 8():. PubMed ID: 35419549
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.
Wang L; Yin H; Cui P; Hetu M; Wang C; Monro S; Schaller RD; Cameron CG; Liu B; Kilina S; McFarland SA; Sun W
Dalton Trans; 2017 Jun; 46(25):8091-8103. PubMed ID: 28604869
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H
Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487
[TBL] [Abstract][Full Text] [Related]
10. A Multi-action and Multi-target Ru
Karges J; Yempala T; Tharaud M; Gibson D; Gasser G
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7069-7075. PubMed ID: 32017379
[TBL] [Abstract][Full Text] [Related]
11. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
Mo J; Mai Le NP; Priefer R
Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
[TBL] [Abstract][Full Text] [Related]
13. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia.
Liu X; Li G; Xie M; Guo S; Zhao W; Li F; Liu S; Zhao Q
Dalton Trans; 2020 Aug; 49(32):11192-11200. PubMed ID: 32748922
[TBL] [Abstract][Full Text] [Related]
14. Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia.
Roque Iii JA; Cole HD; Barrett PC; Lifshits LM; Hodges RO; Kim S; Deep G; Francés-Monerris A; Alberto ME; Cameron CG; McFarland SA
J Am Chem Soc; 2022 May; 144(18):8317-8336. PubMed ID: 35482975
[TBL] [Abstract][Full Text] [Related]
15. Cyclometalated Ruthenium(II) Complexes Derived from α-Oligothiophenes as Highly Selective Cytotoxic or Photocytotoxic Agents.
Ghosh G; Colón KL; Fuller A; Sainuddin T; Bradner E; McCain J; Monro SMA; Yin H; Hetu MW; Cameron CG; McFarland SA
Inorg Chem; 2018 Jul; 57(13):7694-7712. PubMed ID: 29927243
[TBL] [Abstract][Full Text] [Related]
16. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
17. Ru(II) Polypyridine Complex-Functionalized Mesoporous Silica Nanoparticles as Photosensitizers for Cancer Targeted Photodynamic Therapy.
Karges J; Díaz-García D; Prashar S; Gómez-Ruiz S; Gasser G
ACS Appl Bio Mater; 2021 May; 4(5):4394-4405. PubMed ID: 35006851
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared absorbing Ru(ii) complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanoma.
Lifshits LM; Roque Iii JA; Konda P; Monro S; Cole HD; von Dohlen D; Kim S; Deep G; Thummel RP; Cameron CG; Gujar S; McFarland SA
Chem Sci; 2020 Nov; 11(43):11740-11762. PubMed ID: 33976756
[TBL] [Abstract][Full Text] [Related]
19. A novel ruthenium polypyridyl complex for the selective imaging and photodynamic targeting of the Golgi apparatus.
Zhao F; Wang W; Wu W
Dalton Trans; 2021 Mar; 50(10):3536-3541. PubMed ID: 33599670
[TBL] [Abstract][Full Text] [Related]
20. Near-IR/Visible-Emitting Thiophenyl-Based Ru(II) Complexes: Efficient Photodynamic Therapy, Cellular Uptake, and DNA Binding.
Zhang SQ; Meng TT; Li J; Hong F; Liu J; Wang Y; Gao LH; Zhao H; Wang KZ
Inorg Chem; 2019 Oct; 58(20):14244-14259. PubMed ID: 31595752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
